Vincent van der Velden

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

Rob Pieters, Hester de Groot‐Kruseman, Vincent van der Velden et al. · Journal of Clinical Oncology · 2016 · 365 citations · Full text

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 357 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten et al. · Haematologica · 2017 · 89 citations · Full text

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

Michaela Nováková, Markéta ŽAliová, Martina Suková et al. · Haematologica · 2016 · 67 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Immunology +18

Fluorochrome choices for multi-color flow cytometry

Juan Flores‐Montero, Tomáš Kalina, Alba Corral-Mateos et al. · Journal of Immunological Methods · 2019 · 51 citations

Fluorochrome Choices, Cytometry, Molecular Imaging +3